Nature Medicine·6 OctOral small-molecule GLP-1RA safiglipron versus dapagliflozin in type 2 diabetes: a randomized, double-blind, active-comparator-controlled phase 3 trialTrial in peopleInterventionsPaper
Diabetes Research and Clinical Practice·25 AugThe impact of new obesity definitions on prevalence and health outcomesCohort study of 498,353 peoplePopulationsPaper